On February 23, Air Canada hosted yet another spectacular send-off, this time for Team Canada’s Paralympic athletes.
For Tyler McGregor, the secret to success is consistency and chaos – or at least, learning to make the most of chaos.
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...
AZoLifeSciences on MSN
Plant Protein Structure Provides New Insights Into Human Cancer and Better Crops
Can the bend of a banana give us insight into cancer? What does the shape of a rice grain have to do with infertility? The ...
Pro-inflammatory M1 macrophages involved in immune responses accelerate the progression of melanoma through the extracellular ...
News-Medical.Net on MSN
Armored CAR T cells overcome tumor defenses in solid cancers
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block ...
Researchers say study findings have highlighted biomarkers that could help improve early diagnosis of esophageal cancer, when it is easier to treat.
Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
News-Medical.Net on MSN
Distinct spatial tumor–immune ecosystems predict lung cancer treatment response
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
Scientists studying the cellular origins of pineoblastoma discovered a dependency applicable to anatomically distinct brain tumor types, which may be therapeutically targetable. MEMPHIS, Tenn., March ...
The cancer stem cell (CSC) paradigm is pivotal for understanding tumor progression, relapses, and therapeutic failure. Endowed with self-renewal, ...
Schlesinger: For advanced cSCC, immunotherapy has been a game-changer. The first immunotherapy drugs approved in the space were PD-1 inhibitors such as cemiplimab (Libtayo; Regeneron) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results